Zydus Lifesciences Ltd - Artha Sootra

Overview (04 Nov 2026)

Zydus Lifesciences Ltd

ZYDUSLIFE

INE010B01027

Pharmaceuticals

-49

Prev. Close

Previous Close

1239

Current Close

1190

Current High

1266.15

Current Low

1182.05

52 Week High

1266.15

52 Week Low

835.85

Resistance 1

1243.41

Resistance 2

1296.83

Support 1

1159.31

Support 2

1075.21

Std Deviation

3.23%

DMA 200

1036.17

DMA 50

1153.50

DMA 20

1156.63

Fundamentals and Ratios

Standalone

Trailing EPS

35.38

Forwad EPS

36.85

Trailing P/E

33.63

Forward P/E

32.29

PEG Ratio

Mkt. Cap (Cr)

Market Cap (Cr)

119741.84

Total Debt(Cr)

Tot. Debt(Cr)

NA

Reserve (Cr)

NA

Book Value

NA

P/BV Ratio

NA

ROCE(%)

N/A

ROE

N/A

Financial Result

Standalone

Type	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	3482	2872.2	3740.9	2283.6	2871.2	11484
Other Income	164.60	123.70	495.10	473.80	541.50	1667.50
Total Income	3646.60	2995.90	4236.00	2757.40	3412.70	13151.50
Interest	101.40	103.10	115.50	116.00	113.80	482.90
Expenditure	-2682.60	-2540.20	-2018.20	-2344.90	-1969.10	-8602.70
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-155.40	-151.90	-150.90	-144.30	-136.00	-561.20
PBT	962.10	455.70	2111.00	352.40	1443.60	4381.90
Tax	-247.60	-116.10	-389.00	-55.90	-287.00	-822.10
Equity	99.80	99.80	100.60	100.60	0.00	100.60
OPM	26.38	15.21	49.83	12.78	50.28	33.32
Net Profit	714.5	339.6	1722	296.5	1156.6	3559.8
NPM	19.59	11.34	40.65	10.75	40.28	27.07
EPS	7.15	3.38	17.11	2.95	11.49	35.38

Consolidated

Type	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	7909.6	8017	7587	6864.5	6123.2	27148.4
Other Income	129.90	106.10	134.20	111.40	109.00	509.50
Total Income	8039.50	8123.10	7721.20	6975.90	6232.20	27657.90
Interest	187.00	156.00	123.00	129.90	101.30	438.90
Expenditure	-6806.60	-6798.30	-5664.00	-5537.60	-4510.60	-20520.20
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-604.50	-554.70	-508.40	-359.60	-301.90	-1408.00
PBT	1234.20	1306.60	1659.70	1353.40	1687.40	6621.10
Tax	-334.00	-354.20	-318.40	-388.30	-454.00	-1594.70
Equity	99.80	99.80	100.60	0.00	0.00	100.60
OPM	15.35	16.08	21.50	19.40	27.08	23.94
Net Profit	927.7	990.2	1341	1022.9	1238.6	5123.5
NPM	11.54	12.19	17.37	14.66	19.87	18.52
EPS	9.28	9.35	12.65	10.36	12.51	50.09

Annual Reports

Corporate Action

Quarterly Result

Dividend

Year	Dividend Type	Amount	Remark	Ex Date
2026	Final Dividend	1.00	Final Dividend - Rs. - 1.0000	24 Jul 2026
2025	Final Dividend	11.00	Final Dividend - Rs. - 11.0000	25 Jul 2025
2024	Final Dividend	3.00	Final Dividend - Rs. - 3.0000	26 Jul 2024
2023	Final Dividend	6.00	Final Dividend - Rs. - 6.0000	28 Jul 2023
2022	Final Dividend	2.50	Final Dividend - Rs. - 2.5000	28 Jul 2022
2021	Final Dividend	3.50	Final Dividend - Rs. - 3.5000	28 Jul 2021
2020	Interim Divvidend	3.50	Interim Dividend - Rs. - 3.5000	23 Mar 2020
2019	Final Dividend	3.50	Final Dividend - Rs. - 3.5000	25 Jul 2019
2018	Final Dividend	3.50	Dividend - Rs. - 3.5000	31 Jul 2018
2017	Interim Divvidend	3.20	Interim Dividend - Rs. - 3.2000	16 Mar 2017
2016	Interim Divvidend	3.20	Interim Dividend - Rs. - 3.2000	17 Mar 2016
2015	Final Dividend	12.00	Dividend - Rs. - 12.0000	30 Jul 2015
2014	Final Dividend	9.00	Dividend - Rs. - 9.0000	17 Jul 2014
2014	Interim Divvidend	7.50	Interim Dividend - Rs. - 7.5000	11 Jun 2013
2012	Final Dividend	7.50	Dividend - Rs. - 7.5000	26 Jul 2012
2011	Final Dividend	6.25	Dividend - Rs. - 6.2500	07 Jul 2011
2010	Final Dividend	5.00	Dividend - Rs. - 5.0000	15 Jul 2010
2009	Final Dividend	4.50	Dividend - Rs. - 4.5000	16 Jul 2009
2008	Final Dividend	4.50	Dividend - Rs. - 4.5000	10 Jul 2008

Bonus

Year	Ratio	Remark	Ex Date
2010	1:2	Bonus issue 1:2	05 Apr 2010

Split

Year	Ratio	Remark	Ex Date
2015	Rs.5/- to Rs.1/-	Stock Split From Rs.5/- to Rs.1/-	06 Oct 2015

Mutual Fund Holddings

Sector peers

Sector: Pharmaceuticals

Company

Current Close

P/E Ratio

1773.4

130.40

10037.5

90.60

4738.5

83.32

2323.8

120.09

1188.1

38.84

1374

413.86

1402

42.73

2537.9

45.48

1705

36.07

2008.6

16.42

1